SX-GLP1

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameSX-GLP1
Drug Alias Nameglucagon-like peptide-1 agonists (Serometrix)GLP-1 agonists (Serometrix)SX-GLP1
ClassificationSmall molecules > Peptidomimetic
Mechanisms of ActionGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSerometrix LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSerometrix LLC
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A